UMMC Cell Therapy Laboratory

The UMMC Cell Therapy Laboratory is a cell engineering laboratory that provides hematopoietic stem cells (HSCs) and other hematopoietic and non-hematopoietic cell types derived from a variety of sources [bone marrow, peripheral blood, umbilical cord blood (UCB) and various tissues] for hematopoietic reconstitution and novel somatic cellular therapies. 

The laboratory processes over 1000 cellular products, including 700 autologous, allogeneic-related and allogeneic-unrelated peripheral blood, UCB, bone marrow, and tissue products annually in support of the Blood and Marrow Transplant Program at University of Minnesota Medical Center, Fairview.

The laboratory annually processes over 1000 cellular products, and operates 24 hours a day.

The laboratory is staffed with medical laboratory scientists and lead technologists and is a valuable resource for clinical protocols and translational development of novel, complex cellular engineering methods.

The laboratory operates 24 hours a day and the main processing space occupies 3,600 sq ft within the MCT building.  The laboratory is comprised of three main cell processing rooms, four individual pass-through rooms, a supply and material storage room, a liquid nitrogen storage tank, and a dedicated loading dock. 


The UMMC Clinical Cell Therapy Laboratory is Clinical Laboratory Improvement Amendments (CLIA) approved and accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), College of American Pathologists (CAP), and AABB.